Santo Venture Capital

Santo Venture Capital operates as a German venture capital firm, serving as the dedicated investment arm of the Strüngmann family office (ATHOS Service). The firm primarily conducts Series A and later-stage investments, specializing in European enterprises within the healthcare, biopharma, energy, and industrial innovation sectors. It employs deep sector expertise and a robust network to identify and support market-leading and transformative technological advancements.

Established in 2011 and headquartered in Holzkirchen, Santo Venture Capital emerged from the strategic decision of the Strüngmann family office to actively deploy capital into high-growth, innovative companies. The family's significant background and success in the pharmaceutical industry naturally inform the firm's focus on life sciences, extending their entrepreneurial legacy through strategic venture investments.

The firm's clientele consists of ambitious European startups and scale-ups, seeking significant capital and strategic guidance to accelerate their development. Santo Venture Capital’s long-term vision centers on fostering the growth of impactful businesses that drive innovation and establish themselves as leaders within their respective industries, leveraging the profound operational experience and resources of its parent family office.